Clinical Report: Long-Term Survival in ALK-Positive Lung Adenocarcinoma Patient

Overview

This case report details a 47-year-old woman with ALK-positive lung adenocarcinoma and spinal cord metastases who experienced improved muscle strength and quality of life following acupuncture therapy. The overall survival period after the diagnosis of spinal cord metastases exceeded 9 months.

Background

Lung carcinoma is a leading cause of cancer-related mortality globally, with spinal cord metastases indicating advanced disease and poor prognosis. Standard treatments often fail to address neurological recovery, which is crucial for patient survival.

Data Highlights

No numerical data or trial data presented in the article.

Key Findings

• The patient was a 47-year-old female diagnosed with ALK-positive lung adenocarcinoma and spinal cord metastases.
• Systemic therapy reduced tumor burden but worsened limb strength.
• Acupuncture treatment led to enhanced muscle strength and improved quality of life.
• The overall survival period from the diagnosis of spinal cord metastases was greater than 9 months.
• Neurological recovery is emphasized as a primary objective in managing spinal cord metastases.

Clinical Implications

Further investigation into the efficacy of acupuncture in this context is warranted.

Conclusion

This case highlights the importance of addressing neurological recovery in patients with spinal cord metastases.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. NCI, Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC, 2024 -- Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC
6. ACR, Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis, 2026 -- Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis
7. Integrative Medicine for Pain Management in Oncology: Society for Integrative Oncology–ASCO Guideline
8. Lorbrena Effective as Initial Treatment of ALK-Positive NSCLC - NCI
9. Metastatic Epidural Spinal Cord Compression and Recurrent Spinal Metastasis